Article Sidebar

pdf
Date Published: 25/06/2025
Abstract Views: 142
Views pdf: 60
DOI: https://doi.org/10.51298/vmj.v551i2.14657
Issue
Vol. 551 No. 2 (2025)
Section
Các bài báo
How to Cite
Bạch Quốc, K., & Trần Hoài, T. (2025). OUTCOMES OF SPLENECTOMY IN THE TREATMENT OF CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA IN CHILDREN AT THE NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION, 2020–2023. Vietnam Medical Journal, 551(2). https://doi.org/10.51298/vmj.v551i2.14657

OUTCOMES OF SPLENECTOMY IN THE TREATMENT OF CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA IN CHILDREN AT THE NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION, 2020–2023

Khánh Bạch Quốc, Thu Trần Hoài

Main Article Content

Abstract

Background: Splenectomy Outcomes in Pediatric Chronic ITP: 2020–2023, National Institute of Hematology and Blood Transfusion. Objectives: Evaluation of splenectomy effectiveness in pediatric chronic primary immune thrombocytopenia at the National Institute of Hematology and Blood Transfusion (2020–2023). Subjects and methods: A retrospective descriptive study with longitudinal follow-up was conducted on 26 pediatric patients, aged 5 to 16 years, diagnosed with primary chronic immune thrombocytopenia, who underwent splenectomy as a treatment modality. Results: Response rates were 88.5% at 1 week, 80.8% at 1 month, 73.1% at 6 months, and 69.2% at 1 year, with a 57.7% complete response at 1 year without additional therapy. Severe infections occurred in 2 cases (0,07%), with no thrombosis reported. Conclusions: Splenectomy is an effective treatment for pediatric chronic immune thrombocytopenia, with a one-year response rate of 69.2%. Infectious complications occur at a low rate (7,7%).

Article Details

Keywords

Immune thrombocytopenic purpura, chronic, children, splenectomy

References

1. Bennett CM, Tarantino M. Chronic immune thrombocytopenia in children: epidemiology and clinical presentation. Hematol Oncol Clin North Am. 2009;23(6):1223-1238.
2. Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780-3817.
3. Neunert C, Terrell DR, Arnold DM. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-3866.
4. Aladjidi N, Santiago R, Pondarré C, et al. Revisiting splenectomy in childhood chronic immune thrombocytopenia at the era of new therapies: The French experience. Blood. 2011;118:2227.
5. Vianelli N, Palandri F, Polverelli N, et al. Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years. Haematologica. 2013;98(6): 875-880. doi:10. 3324/haematol.2012.075648.
6. Gupta AK, Vazquez OA. Overwhelming Post-Splenectomy Infection Syndrome: Variability in Timing With Similar Presentation. Cureus. 2020;12(8):e9914. Published 2020 Aug 21. doi:10.7759/cureus.9914.
7. Barmparas G, Lamb AW, Lee D, et al. Postoperative infection risk after splenectomy: A prospective cohort study. Int J Surg. 2015;17:10-14. doi:10.1016/j.ijsu.2015.03.007.
8. Bộ Y tế. Giảm tiểu cầu miễn dịch nguyên phát, Hướng dẫn chẩn đoán và điều trị một số bệnh huyết học; 2022.
9. Wang T, Xu M, Ji L, Yang R. Splenectomy for chronic idiopathic thrombocytopenic purpura in children: a single center study in China. Acta Haematol. 2006;115(1-2): 39-45. doi:10.1159/ 000089464.
10. Kühne T. Diagnosis and management of immune thrombocytopenia in childhood. Hamostaseologie. 2017; 37(1): 36-44. doi:10.5482/HAMO-16-06-0017.